Morgans analyst Scott Power said momentum is returning to the ASX healthcare sector, which is up 4.3% in the past ... Read ...

Depression is a common mental disorder. Some 300 million people in the world have it, or an estimated 3.8% of the population, ...

At Butler Hospital in Providence, Rhode Island, Dr. Linda Carpenter, M.D., talks about the successful completion of clinical ...

Psilocybin effects on depression and anxiety are generally safe and well-tolerated, but researchers should focus on determining optimal dosage.

eHarvard T H Chan, School of Public Health, Harvard University, Boston, MA, USA ...

Scientists found disrupted brain connectivity in youth depression, especially in networks tied to introspection and attention ...

It’s the time of year for symptoms of seasonal affective disorder. The 40-year-old term has stuck despite diagnostic manuals ...

Struggling with your mental health, constantly feeling stressed, and being in chronic pain is a very difficult situation to ...

Cybin, Inc. ( (CYBN) ) has released its Q2 earnings. Here is a breakdown of the information Cybin, Inc. presented to its investors.Don't Miss ...

In the US, liraglutide, semaglutide, and tirzepatide are currently under investigation for their ability to stimulate weight ...

BETR-002, which is in preclinical and IND-enabling studies, is based on honokiol, the active anxiolytic ingredient of magnolia bark. BetterLife’s pending method of use and formulations patent covers ...